Offstream
news

Moderna announces that it will supply 12 million doses of its bivalent COVID-19 vaccine aimed at targeting the Omicron variant.
2022-08-22

The European Commission announces a binding proposal that will make the EU Digital COVID Certificate only valid for travel within the European Union for nine months without a booster dose after a person's primary vaccination schedule in order to standardize different travel requirements in the member states. The new rules will be mandatory for all 27 EU member states beginning on February 1.
2021-12-21

The European Medicines Agency approves the usage of the Moderna COVID-19 vaccine for children between the ages of 12 and 17, becoming the first time the vaccine has been authorised for people under the age of 18.
2021-07-23

Saudi Arabia approves the COVID-19 vaccine developed by Moderna.
2021-07-9

The United States government purchases 200 million doses of the vaccine produced by Moderna.
2021-06-16

Moderna says its vaccine is 90% effective against COVID-19, and 95% effective against severe disease for six months after the second dose. It also says its vaccine is effective against the 501.V2 variant from South Africa.
2021-04-13

Moderna signs a supply deal with the government to supply 13 million doses of its COVID-19 vaccine from mid-2021.
2021-03-6

United States Forces Korea begins a vaccination programme against COVID-19 using the Moderna vaccine. Healthcare providers and first responders are among those who will initially receive the vaccine.
2020-12-29

The United States begins shipping the COVID-19 vaccine made by Moderna.
2020-12-20

The Trump administration announces that they will purchase an additional 100 million doses of Moderna's vaccine.
2020-12-11